Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer

Thyroid. 2023 Feb;33(2):138-142. doi: 10.1089/thy.2022.0428. Epub 2022 Nov 30.

Authors

Leila Shobab¹, Leonard Wartofsky²

Affiliations

¹ MedStar Washington Hospital Center, Washington, District of Columbia, USA.
² MedStar Health Research Institute, Washington, District of Columbia, USA.

PMID: 36345225
DOI: 10.1089/thy.2022.0428

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma*
Humans
Iodine Radioisotopes / therapeutic use
Thyroid Neoplasms* / genetics
Thyroid Neoplasms* / radiotherapy

Substances

Iodine Radioisotopes